Skip To Main Content

Polivy (polatuzumab vedotin-piiq)

Publications icon

Publications and Congresses

The information in this section may include content beyond what is in the FDA-approved label. Because the FDA has not approved such content, no conclusions regarding safety or efficacy may be made. Providing this information should not be construed as recommendation for use of a Genentech product for unapproved uses. For FDA-approved products please consult the product’s full prescribing information for a complete discussion of risks and benefits of the product(s) for its approved indication(s).

Publications: The list of publications is not an exhaustive list of published materials on the product. The list of references by data topics is selected per evidence-based medicine criteria. To browse a full listing of published scientific literature:

Congresses: The list of congresses is a subset of Roche/Genentech posters and oral presentations for the product with data presented at scientific meetings in the recent 24 months. To browse full Roche/Genentech congress presentations and posters:


Filters

Polatuzumab Vedotin Data Topics

Showing 20 out of 20 results

No results

Try resetting the filters or selecting another category.

Reset filters

Looking for more information?

Reach out to a Genentech Medical Science Liaison near you, or connect with the contact center.

Call Us: 1-800-821-8590 Hours: Monday-Friday, 5am-5pm PT

Clinical trials icon

Clinical Trials

Find information about active clinical research for Polivy® at ClinicalTrials.gov and information about our research at Genentech Clinical Trials.

Additional resources icon

Additional Resources

For additional information or assistance regarding Polivy®, use the links below.

Connect with a Medical Science Liaison

Browse the Genentech Medical Information Library